Tianjin Medical University General Hospital
Clinical trials sponsored by Tianjin Medical University General Hospital, explained in plain language.
-
Promising drug may halt devastating attacks in rare brain disorder
Disease control Recruiting nowThis study tests whether eculizumab can quickly reduce disability during acute attacks of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that damages the brain and spinal cord. About 110 adults who test positive for the AQP4 antibody and are having an a…
Phase: PHASE2 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Massive genetic diabetes study launches in china
Knowledge-focused Recruiting nowThis study is creating a large digital registry for people with monogenic diabetes (a rare form caused by a single gene). Researchers will use a mobile app and website to enroll up to 5,000 participants and perform genetic testing. The goal is to learn more about the genetic caus…
Sponsor: Tianjin Medical University General Hospital • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC